31 May 2023
2023 ISCT Paris
Proud Platinum sponsors, ScaleReady will be hosting a Corporate Breakfast Session on June 1 at 8am, join us for our Global Showcase Presentation at 12:45 pm and at 3:45 pm our Roundtable - we hope to see you there! Stop by booth # 84 to learn more!
20 May 2023
TestMeet the Team! Curabitur blandit mollis Alex Spyridonidis Sed a libero Sed a libero Vivamus aliquet elit ac nisl. Class...
16 May 2023
26th Annual ASGCT Meeting
Standardize Your Cell Therapy Process Today! Meet the ScaleReady team in booth 723 at the Los Angeles Convention Center and block your calendar for our Tools and Technology Forum presentation Thursday at 2:45 pm.
11 May 2023
Cellular Origins Partners With ScaleReady to Simplify, Standardize, and Automate Cell Therapy Manufacturing
Partnership aims to integrate ScaleReady’s CGT manufacturing workflow with Cellular Origins’ robotic technology Initially focussed on automation of ScaleReady’s G-Rex platform
3 May 2023
20th Annual CIMT Meeting 2023
Meet the ScaleReady team at the 20th Annual CIMT 2023 meeting in Mainz, Germany. Our team is ready to help you optimize your process and on-hand we will have the Fresenius Kabi Lovo cell processing system, G-Rex Bioreactor and reagents as we explore how to get your program to market faster.
14 April 2023
Lovo®. The first step toward high-throughput patient processing.Morbi mattis ullamcorper Fusce fermentum odio nec arcu. Donec orci lectus, aliquam ut, faucibus non, euismod id, nulla. Praesent egestas...
13 April 2023
BioCentury Article: Cell and gene therapy must prioritize simplification, standardization before focusing on automationJosh Ludwig, Global Director of Commercial Operations at ScaleReady, reviews how the industry is addressing the challenges that come with...
1 March 2023
Bio-Techne Announces Investment in Wilson WolfBio-Techne Corporation announced Wilson Wolf Manufacturing has met the trailing 12-month earnings before interest, taxes, depreciation, and amortization (EBITDA) target...
9 February 2023
For the Record - Medical Alley Interview with Josh Ludwig
26 April 2022
Marker Therapeutics Announces Entry into Services Agreement with Wilson WolfHOUSTON, April 26, 2022 (GLOBE NEWSWIRE) -- -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the...
14 December 2021
Bio-Techne Announces Future Wilson Wolf Purchase AgreementBio-Techne announced it has entered into a purchase option agreement with Wilson Wolf Corporation, solidifying resources and support for ScaleReady...
10 November 2021
ScaleReady Launches Second Generation of Wilson Wolf G-Rex ProductThe second generation G-Rex500M-CS improves on the materials and ergonomics of the original G-Rex while retaining the same cell expansion...